As the intestinal barrier was compromised, LPS entered the circulation and stimulates the body to produce excessive pro-inflammatory factors (e.g., IL-1β, IL-6, and TNFα, etc.), which further exacerbated the systemic inflammatory response in patients with DN (Salguero et al., 2019). The gene discussed is IL1B; the disease is liver dysplastic nodule.